Currently, patients who are admitted to the ER with cannabis intoxication have no other option but to wait in the hospital until they become sober — taking up valuable resources and delaying other patients. Estimates suggest that more than 1.7 million emergency room visits in 2018 were associated with THC. Anebulo Pharmaceuticals (NASDAQ:ANEB) is a clinical-stage biotech company whose lead product, ANEB-001, is a promising antidote for cannabis intoxication. Anebulo’s development is significant because there are currently no approved medical treatments for alleviating the symptoms of cannabis intoxication. Instead, patients who head into the emergency room with cannabis intoxication have no other option but to wait in the hospital until they become sober — taking up valuable resources and delaying other patients.
420 Intel – Marijuana Industry News, 07/12/2021 20:00:00